Live News Categoriesmarket

ASXNYR (ASXNYR) News

Follow ASXNYR (ASXNYR) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol ASXNYR Asset market Sector Markets 90 days 0 Updated Jul 06, 2026, 01:03 AM UTC Open live news feed

L Nyrada Doses First Patient in Phase 2a Trial of Heart Attack Drug Candidate () -- Nyrada (ASX:NYR) has initiated its PROTECT-MI phase 2a clinical trial with the dosing of the first patient evaluating its transient receptor potential canonical ion channel inhibitor Xolatryp, according to a Monday EQUITY | Jul 06, 2026, 01:03 AM UTC